The Orange Book is an important resource for generic drug development. Generic drugs offer lower prices to consumers, and should be supported by the federal government through initiatives such as the Orange Book.
The patent invalidation process can be lengthy if the patent holder appeals, so keeping the Orange Book current may prove difficult. This bill could harm innovation in the pharmaceutical and medical device industries by empowering generic manufacturers.